Angiotensin-converting enzyme 2: a new player in central sympathetic regulation?

Circ Res. 2008 Mar 28;102(6):628-9. doi: 10.1161/CIRCRESAHA.108.173781.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Angiotensin II / administration & dosage
  • Angiotensin II / metabolism*
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Baroreflex* / drug effects
  • Blood Pressure
  • Cell Line, Tumor
  • Culture Media / metabolism
  • Down-Regulation
  • Drinking Behavior* / drug effects
  • Heart Rate
  • Humans
  • Injections, Intraventricular
  • Mice
  • Neurons / enzymology
  • Neurons / metabolism*
  • Peptidyl-Dipeptidase A / genetics
  • Peptidyl-Dipeptidase A / metabolism*
  • Receptor, Angiotensin, Type 1 / agonists
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Receptor, Angiotensin, Type 2 / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction
  • Subfornical Organ / drug effects
  • Subfornical Organ / enzymology
  • Subfornical Organ / metabolism*
  • Sympathetic Nervous System / enzymology
  • Sympathetic Nervous System / metabolism*
  • Time Factors
  • Transduction, Genetic
  • Up-Regulation

Substances

  • Culture Media
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Recombinant Fusion Proteins
  • Angiotensin II
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, mouse
  • Angiotensin-Converting Enzyme 2